News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

|Videos|October 12, 2021

Pros and Cons of Available Influenza Vaccines

Author(s)Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS, John J Russell, MD, FAAFP, Stephan Foster, PharmD, FAPhA, FNAP

Episodes in this series

Experts on Influenza

EP. 1 Evolving Influenza Trends Throughout COVID-19 Pandemic

Experts on Influenza

EP. 2 The Impact of Distancing, Masks, and Vaccination on Influenza

Experts on Influenza

EP. 3 Feasibility of Concurrent COVID-19 and Influenza Vaccination

Experts on Influenza

EP. 4 Similarities and Differences in COVID-19 and Influenza

Experts on Influenza

EP. 5 Identifying Patients at High Risk for Influenza Complications

Experts on Influenza

EP. 6 Pros and Cons of Available Influenza Vaccines

Experts on Influenza

EP. 7 Influenza Vaccination Timing and Reluctance

Experts on Influenza

EP. 8 Vaccination Misconceptions and Educating Patients

Experts on Influenza

EP. 9 Influenza Case 1: Female Patient With Asthma and Egg Allergy

Experts on Influenza

EP. 10 Influenza Case 2: Male Patient With Chronic Health Conditions

Charles Vega, MD, discusses the indications, administration requirements, dosing schedules, adverse events, and any contraindications that exist between each available influenza vaccines that is currently available.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Latest CME

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

Facing the contemporary challenges in health care

Asset protection strategies and why it matters

Administrative overload is painful and prevents healthy growth

The new era of physician independence

Digital twin technology: Improving workflows and patient safety in primary care

© 2025 MJH Life Sciences^®

All rights reserved.